Evidence map›Paper›PMID 38665238›Full record

ArticleNpj viruses2023

An HIV-1 broadly neutralizing antibody overcomes structural and dynamic variation through highly focused epitope targeting.

Edgar A Hodge, Ananya Chatterjee, Chengbo Chen, Gajendra S Naika, Mint Laohajaratsang, Vidya Mangala Prasad, Kelly K Lee

Open access · diamondAbstract read
In one paragraph

Article in Npj viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Edgar A HodgeDepartment of Medicinal Chemistry, University of Washington, Seattle, WA 98195 USA.
Ananya ChatterjeeMolecular Biophysics Unit, Indian Institute of Science, Bangalore, Karnataka 560012 India.
Chengbo ChenDepartment of Medicinal Chemistry, University of Washington, Seattle, WA 98195 USA.
Gajendra S NaikaDepartment of Medicinal Chemistry, University of Washington, Seattle, WA 98195 USA.
Mint LaohajaratsangDepartment of Medicinal Chemistry, University of Washington, Seattle, WA 98195 USA.
Vidya Mangala PrasadDepartment of Medicinal Chemistry, University of Washington, Seattle, WA 98195 USA.
Kelly K LeeDepartment of Medicinal Chemistry, University of Washington, Seattle, WA 98195 USA.
University of Washington · USIndian Institute of Science Bangalore · IN

Funding

Structural and dynamic traits underlying phenotypic variation in HIV-1 EnvR01AI140868 · NIAID · UNIVERSITY OF WASHINGTON · PI Kelly Keisen Lee · 2019 to 2026
$5.3M
NIAID NIH HHS R01 AI140868
6 · The paper itself

Abstract

The existence of broadly cross-reactive antibodies that can neutralize diverse HIV-1 isolates (bnAbs) has been appreciated for more than a decade. Many high-resolution structures of bnAbs, typically with one or two well-characterized HIV-1 Env glycoprotein trimers, have been reported. However, an understanding of how such antibodies grapple with variability in their antigenic targets across diverse viral isolates has remained elusive. To achieve such an understanding requires first characterizing the extent of structural and antigenic variation embodied in Env, and then identifying how a bnAb overcomes that variation at a structural level. Here, using hydrogen/deuterium-exchange mass spectrometry (HDX-MS) and quantitative measurements of antibody binding kinetics, we show that variation in structural ordering in the V1/V2 apex of Env across a globally representative panel of HIV-1 isolates has a marked effect on antibody association rates and affinities. We also report cryo-EM reconstructions of the apex-targeting PGT145 bnAb bound to two divergent Env that exhibit different degrees of structural dynamics throughout the trimer structures. Parallel HDX-MS experiments demonstrate that PGT145 bnAb has an exquisitely focused footprint at the trimer apex where binding did not yield allosteric changes throughout the rest of the structure. These results demonstrate that structural dynamics are a cryptic determinant of antigenicity, and mature antibodies that have achieved breadth and potency in some cases are able to achieve their broad cross-reactivity by "threading the needle" and binding in a highly focused fashion, thus evading and overcoming the variable properties found in Env from divergent isolates.

Indexed as

BiochemistryImmunologyMicrobiology

Identifiers

PMID38665238
PMCPMC11041648
OpenAlexW4387372919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.